Tag Archives: Schering-Plough

Merck’s frivolous patent on asthma inhaler revoked

Posted on December 12, 2012 by donttradeourlivesaway

On 10 December, Schering Corporation’s (now Merck) patent on an asthma inhaler has been revoked. In 2004, Schering Corporation filed an application (402/CHENP/2004) in India claiming a product patent on an aerosol suspension formulation containing two active drugs mometasone furoate and formoterol fumarate. These drugs … Continue reading →

Posted in Indian Patent Law, Patent Opposition, Post-grant opposition | Tagged , , | Leave a comment

Cipla slashes prices of anticancers in India

Posted on May 7, 2012 by donttradeourlivesaway

Source: Scrip Intelligence 03 May 2012, Anju Ghangurde Cipla has announced price cuts of about 60% or more across a clutch of oncology products, including its generic version of AstraZeneca’s lung cancer therapy, Iressa (gefitinib), in India. Cipla said that it … Continue reading →

Posted in Pricing | Tagged , , , , , | 18 Comments